Surbhi Leekha
Associate Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Dr. Surbhi Leekha is an Associate Professor at the University of Maryland Baltimore, United States. Her research focuses on improving antibiotic use and infection control, particularly in the context of respiratory viruses and antimicrobial stewardship. Recent articles authored by Dr. Leekha highlight her expertise in diagnostic stewardship and the management of multidrug-resistant infections.
Articles (9)
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Background Early detection of multidrug-resistant Pseudomonas aeruginosa (MDRP) remains challenging. Existing risk prediction tools are difficult to translate to bedside application. The goal of this study was to develop a simple electronic medical record (EMR)–integrated tool for prediction of MDRP infection. Methods This was a mixed-methods study. We conducted a split-sample cohort study of adult critical care patients with P aeruginosa infections. Two previously published tools were validated using c-statistic. A subset of variables based on strength of association and ease of EMR extraction was selected for further evaluation. A simplified tool was developed using multivariable logistic regression. Both c-statistic and theoretical trade-off of over- versus underprescribing of broad-spectrum MDRP therapy were assessed in the validation cohort. A qualitative survey of frontline clinicians assessed understanding of risks for MDRP and potential usability of an EMR-integrated tool to predict MDRP. Results The 2 previous risk prediction tools demonstrated similar accuracy in the derivation cohort (c-statistic of 0.76 [95% confidence interval {CI}, .69–.83] and 0.73 [95% CI, .66–.8]). A simplified tool based on 4 variables demonstrated reasonable accuracy (c-statistic of 0.71 [95% CI, .57–.85]) without significant overprescribing in the validation cohort. The risk factors were prior MDRP infection, ≥4 antibiotics prior to culture, infection >3 days after admission, and dialysis. Fourteen clinicians completed the survey. An alert providing context regarding individual patient risk factors for MDRP was preferred. Conclusions These results can be used to develop a local EMR-integrated tool to improve timeliness of effective therapy in those at risk of MDRP infections.
Year:
2023
Year:
2021
Year:
2021
Year:
2020
Collaborators (3)
Kimberly C Claeys
University of Maryland School of Pharmacy
Donald K Milton
University of Maryland School of Public Health
Ravi Tripathi
Assistant Professor
University of Maryland School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.